However, since we showed that BRD4 transcript levels (especially BRD4-L isoform) does not reflect well the BRD4 protein levels in tumors, thus the BRD4 overexpression status in tumor tissues should be evaluated using immunohistochemistry or proteomic methods. Here, BRD4 is linked to neoplasm.